Back to Search Start Over

The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.

Authors :
Yang, Jen-Hau
Presby, Rose E.
Rotolo, Renee A.
Quiles, Taina
Okifo, Kevin
Zorda, Emma
Fitch, Roslyn Holly
Correa, Mercè
Salamone, John D.
Source :
Psychopharmacology. Sep2020, Vol. 237 Issue 9, p2845-2854. 10p. 4 Graphs.
Publication Year :
2020

Abstract

Rationale: Effort-based decision-making tasks allow animals to choose between preferred reinforcers that require high effort to obtain vs. low-effort/low reward options. Mesolimbic dopamine (DA) and related neural systems regulate effort-based choice. Tetrabenazine (TBZ) is a vesicular monoamine transport type-2 inhibitor that blocks DA storage and depletes DA. In humans, TBZ induces motivational dysfunction and depression. TBZ has been shown reliably to induce a low-effort bias in rats, but there are fewer mouse studies. Objectives: The present studies used touchscreen operant procedures (Bussey-Saksida chambers) to assess the effects of TBZ on effort-based choice in mice. Methods: C57BL6 mice were trained to press an elevated lit panel on the touchscreen on a fixed ratio 1 schedule reinforced by strawberry milkshake, vs. approaching and consuming a concurrently available but less preferred food pellets (Bio-serv). Results: TBZ (2.0–8.0 mg/kg IP) shifted choice, producing a dose-related decrease in panel pressing but an increase in pellet intake. In contrast, reinforcer devaluation by pre-feeding substantially decreased both panel pressing and pellet intake. In free-feeding choice tests, mice strongly preferred the milkshake vs. the pellets, and TBZ had no effect on milkshake intake or preference, indicating that the TBZ-induced low-effort bias was not due to changes in primary food motivation or preference. TBZ significantly decreased tissue levels of nucleus accumbens DA. Conclusion: The DA depleting agent TBZ induced an effort-related motivational dysfunction in mice, which may have clinical relevance for assessing novel drug targets for their potential use as therapeutic agents in patients with motivation impairments. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00333158
Volume :
237
Issue :
9
Database :
Academic Search Index
Journal :
Psychopharmacology
Publication Type :
Academic Journal
Accession number :
145949197
Full Text :
https://doi.org/10.1007/s00213-020-05578-w